Biopsafe ApS: Financial statements 2023
CVR: 33575505
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Biopsafe ApS (CVR 33575505) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 7,235,000 and a net result of DKK 79,000 compared with DKK 1,447,000 the year before. That is an increase of 19% compared with the year before. Equity in the 2023 report amounted to DKK 5,079,000. The solvency ratio was 22.3%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 7,235,000
- Profit/Loss
- DKK 79,000
- Equity
- DKK 5,079,000
- Total Assets
- DKK 22,748,000
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 7.2 mio. | 79 t. | 5.1 mio. | 4 |
| 2022 | - | 6.1 mio. | 1.4 mio. | 5.7 mio. | 2 |
| 2021 | - | 7.5 mio. | 250 t. | 4.3 mio. | 3 |
| 2020 | - | 5.2 mio. | 219 t. | 4 mio. | 3 |
| 2019 | - | 6.3 mio. | 268 t. | 3.8 mio. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Biopsafe ApS has published its annual report for 2022. Gross profit came to DKK 6,081,000, and the net result was DKK 1,447,000.
About Biopsafe ApS
Biopsafe ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2011. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named AX-LAB INNOVATION ApS. The management consists of Anne Lykke Gade. The board consists of Anders Dahlberg. The company is owned by MedCap AB (publ). The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 14,274,000 and a net result of DKK 6,231,000 compared with DKK 4,087,000 the year before. Equity in the 2025 report amounted to DKK 11,231,000.